← All stocks

LeonaBio, Inc.

LONA Net selling
CIK 0001620463 #4535 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$99.42K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$99.42K
10 of 10 sales
Net
−$99.42K
−$99.42K against sales at will

By person

6 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Litton Mark James
PRESIDENT and CEO
$45.48K (2)
−$45.48K
57,926
$311.06K
San Martin Javier
CHIEF MEDICAL OFFICER
$20.55K (2)
−$20.55K
15,887
$85.31K
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
$13.32K (2)
−$13.32K
25,178
$135.21K
Worthington Mark
GENERAL COUNSEL and CCO
$13.16K (2)
−$13.16K
18,376
$98.68K
Renninger Robert
CHIEF FINANCIAL OFFICER
$6.91K (2)
−$6.91K
15,851
$85.12K
PERCEPTIVE ADVISORS LLC entity
Director
329,756
$1.77M

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 3,943,887 to 39,439,326 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
San Martin Javier
4 Mar 2026
CHIEF MEDICAL OFFICER
Sell
1,720
$5.37
$9.24K
CHURCH KEVIN
4 Mar 2026
CHIEF SCIENTIFIC OFFICER
Sell
1,359
$5.37
$7.30K
Worthington Mark
4 Mar 2026
GENERAL COUNSEL and CCO
Sell
1,328
$5.37
$7.13K
Renninger Robert
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
906
$5.37
$4.87K
Litton Mark James
4 Mar 2026
PRESIDENT and CEO
Sell
5,156
$5.37
$27.69K
Worthington Mark
2 Jan 2026
General Counsel and CCO
Sell
876
$6.88
$6.03K
CHURCH KEVIN
2 Jan 2026
CHIEF SCIENTIFIC OFFICER
Sell
876
$6.88
$6.03K
Renninger Robert
2 Jan 2026
Chief Financial Officer
Sell
297
$6.88
$2.04K
Litton Mark James
2 Jan 2026
President and CEO
Sell
2,586
$6.88
$17.79K
San Martin Javier
2 Jan 2026
CHIEF MEDICAL OFFICER
Sell
1,644
$6.88
$11.31K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 1,390,251
History held since 22 Sep 2020